Gene Therapy Could Thwart Prostate Cancer Tumor-suppression Mutations, Study Reports

Gene Therapy Could Thwart Prostate Cancer Tumor-suppression Mutations, Study Reports
Prostate cancer patients who have mutations in the tumor suppressor gene PTEN could benefit from therapies targeting the CHD1 gene, according to a study. The research, “Synthetic Essentiality Of Chromatin Remodeling Factor CHD1 In PTEN-deficient Cancer,” was published in the journal Nature. Mutations in the PTEN gene, which prevents the expression, or activation, of cancer-associated

Knowledge is power when living with prostate cancer.

Get access to the web’s leading Prostate Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *